Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.

By T. Inglesby, D. Dennis, D. Henderson, J. Bartlett, M. Ascher, E. Eitzen, Anne D. Fine, A. Friedlander, J. Hauer, John F. Koerner and 9 more. Journal of the American Medical Association (JAMA), 2000

969 citations recorded by the source corpus.

Subfields: Genetics, Molecular Biology, Public Health, Environmental and Occupational Health

View Paper: https://www.semanticscholar.org/paper/adc381baddd5aa2d920f5f138996b936c51a224f

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. L. Mandell
2. S. Delisle
3. Bernard Kim
4. J. Bartlett
5. J. Deepak
6. Tariq Siddiqui
7. S. Dowell
8. A. Gundlapalli

Citations in the corpus

• Practice Guidelines for the Management of Community-Acquired Pneumonia in Adults (2000, neutral): “The standard treatment for plague pneumonia is administration of streptomycin or gentamicin in standard doses for 10 days [187].”
• Update of Practice Guidelines for the Management of Community-Acquired Pneumonia in Immunocompetent Adults (2003, background): “pestis is also a potential biological weapon of great concern because it has a fulminant course, causes death in the absence of antibiotic treatment, and can be spread from person to person [103].”
• Using the Electronic Medical Record to Identify Community-Acquired Pneumonia: Toward a Replicable Automated Strategy (2013, background): “For surveillance systems aimed at epidemics of acute respiratory infections (ARI), the rationale for incorporating information about disease severity is particularly compelling: 1) doing so could help discover outbreaks that involve only a small number of very sick patients, such as what initially o”